Literature DB >> 6994703

Penetrating keratoplasty: changing indications, 1947 to 1978.

R E Smith, H R McDonald, A B Nesburn, D S Minckler.   

Abstract

Corneal buttons submitted to the Estelle Doheny Eye Foundation from 1947 through 1978 were studied. According to a study of 710 corneal specimens processed during 31 years, the leading indications for penetrating keratoplasty were aphakic bullous keratopathy, regrafts, keratoconus, and Fuchs' endothelial dystrophy. Intraocular lenses were associated with 22% of all specimens of aphakic bullous keratopathy in 1974, increasing to 68% of all aphakic bullous keratopathy corneas in 1978. Histopathologic appearance of aphakic bullous keratopathy corneas with or without an intraocular lens was similar.

Entities:  

Mesh：

Year:  1980        PMID： 6994703     DOI： 10.1001/archopht.1980.01020040078009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


  24 in total

1.  Penetrating keratoplasty: indications over a 10 year period.

Authors:  N Al-Yousuf; I Mavrikakis; E Mavrikakis; S M Daya
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty.

Authors:  B C Branco; P A Gaudio; T P Margolis
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

3.  Penetrating keratoplasty for corneal scarring due to herpes zoster ophthalmicus.

Authors:  H K Soong; A E Schwartz; R F Meyer; A Sugar
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

Review 4.  Trends in penetrating keratoplasty in the United States 1980-2005.

Authors:  Faris R Ghosheh; Federico A Cremona; Christopher J Rapuano; Elisabeth J Cohen; Brandon D Ayres; Kristin M Hammersmith; Irving M Raber; Peter R Laibson
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 5.  Adult keratoplasty: has the prognosis improved in the last 25 years?

Authors:  Francis W Price; Marianne O Price
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

6.  A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lily Li; Lucas Chan; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-02-03       Impact factor: 2.643

7.  Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.

Authors:  A B Nesburn; R L Burke; H Ghiasi; S Slanina; S Bahri; S L Wechsler
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  The canonical Wnt/β-catenin signaling pathway stimulates herpes simplex virus 1 productive infection.

Authors:  Liqian Zhu; Clinton Jones
Journal:  Virus Res       Date:  2018-08-02       Impact factor: 3.303

9.  Corneal transplant allograft reaction: possible predisposing factors.

Authors:  J J Arentsen
Journal:  Trans Am Ophthalmol Soc       Date:  1983

10.  A speculated ribozyme site in the herpes simplex virus type 1 latency-associated transcript gene is not essential for a wild-type reactivation phenotype.

Authors:  Dale Carpenter; Sukhpreet Singh; Nelson Osorio; Chinhui Hsiang; Xianzhi Jiang; Ling Jin; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.